Vera Therapeutics VERA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's retained earnings?
- Vera Therapeutics (VERA) reported retained earnings of -$881.9M in Q1 2026.
- How has Vera Therapeutics's retained earnings changed year-over-year?
- Vera Therapeutics's retained earnings decreased by 71.9% year-over-year, from -$512.94M to -$881.9M.
- What is the long-term trend for Vera Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), Vera Therapeutics's retained earnings has grown at a 52.8% compound annual growth rate (CAGR), from -$91.45M to -$760.87M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.